Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Fascial Block

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT05592691UnknownPrimary

Ropivacaine Plasma Concentrations After Fascial Blocks in Elective Cardio-thoracic and Abdominal Surgery

NCT05126394Not ApplicableCompleted

U/S Guided SAPB Versus Conventional IV Analgesics in Postoperative Pain Management in MRM

Showing all 2 trials

Research Network

Common Treatments

  • Fascial Block1
  • Ultrasound Guided Serratus Anterior Plane Block1

Active Sponsors

  • University of Turin, Italy1
  • Ain Shams University1

Top Investigators

Related Conditions

  • Regional Anesthesia Morbidity1
  • Postoperative Pain1
  • Injection Site Haematoma1

Activity Timeline